| P2R Inhibitors Prevent Antibody-Mediated Complement Activation in an Animal Model of Neuromyelitis Optica | 
| Kalluri SR, Srivastava R, (...), Herwerth M | Neurotherapeutics | 2022 | | |
| PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation |
| Linnerbauer M, Beyer T, (...), Rothhammer V | Nature Communications | 2023 | | |
| Phagocyte-mediated synapse removal in cortical neuroinflammation is promoted by local calcium accumulation |
| Jafari M, Schumacher A, (...), Kerschensteiner M | Nature Neuroscience | 2021 | | |
| Plasma Lipidomic Profiling Using Mass Spectrometry for Multiple Sclerosis Diagnosis and Disease Activity Stratification (LipidMS) |
| Lattau SSJ, Borsch L, (...), Fitzner D | International Journal of Molecular Sciences | 2024 | | |
| Plasma lipidomics of monozygotic twins discordant for multiple sclerosis. |
| Penkert H, Lauber C, (...), Simons M | Annals of Clinical and Translational Neurology | 2020 | | |
| Plasticity of callosal neurons in the contralesional cortex following traumatic brain injury |
| Bareyre F, Chovsepian A, Empl L | Neural Regeneration Research | 2022 | | |
| Polyglutamylation of microtubules drives neuronal remodeling |
| Gavoci A, Zhiti A, (...), Brill MS | bioRxiv | 2024 | | |
| Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade | | Roth S, Cao J, (...), Liesz A | Immunity | 2021 | | |
| Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis |
| Galbusera R, Bahn E, (...), Granziera C | Brain Pathology | 2022 | | |
| Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis. |
| Cunha MI, Su M, (...), Simons M | Journal of Experimental Medicine | 2020 | | |
10.1007/s13311-022-01269-w
35821382
